Transcarent is planning to acquire Accolade for $621 million, the companies announced Wednesday. The two companies are very complementary and the deal gives Accolade a chance to turn things around after struggling in the public market, experts say. The post Accolade Gets a Do-Over With Transcarent’s $621M Acquisition appeared first on MedCity News.
Neuroflow acquired Intermountain Health’s behavioral health risk analytics model to integrate into its software platform. The model identifies which patients may be at risk of experiencing mental health crises so that care teams can step in to provide timely support. The post Intermountain Health Sells Its Behavioral Health Risk Model to Neuroflow appeared first on…
Galapagos said the planned business separation will leave the legacy company free to focus on developing cell therapies for cancer. An accompanying corporate restructuring will shave Galapagos’s headcount by 40%. The post Galapagos Keeps Focus on Cancer Cell Therapy, Spins Out Rest of Biz Into NewCo Backed by €2.4B appeared first on MedCity News.
Metabolic medicines dominated life sciences headlines in 2024, a trend expected to continue into the new year. Other things to look for include more widespread adoption of artificial intelligence technologies and the IPO market’s return to normal levels. The post Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More appeared first on…
Certified clinicians and therapists have specific ethical foundations and analytic responsibilities to uphold that might not apply to all members of the healthcare field. The post Understanding the Ethics of AI in ABA Therapy appeared first on MedCity News.
By grounding wellness programs in behavior-change science, employers can empower their people to build healthier, more sustainable habits. The post Study: Why Quick Fixes Don’t Work in Workplace Wellness appeared first on MedCity News.
When it comes to managing inbound phone calls, underperformance has devastating cost implications. The post What Keeps Healthcare CIOs Up at Night: Balancing Technology Investments with Consumer Expectations appeared first on MedCity News.
Novo Nordisk and Valo Health have collaborated on the development of cardiovascular disease drugs since 2023. Expanding the alliance to cardiometabolic diseases nearly doubles the number of programs covered under the agreement. The post Novo Nordisk Adds Obesity and Diabetes to AI Drug Research Pact With Flagship’s Valo Health appeared first on MedCity News.
Time’s almost up to get health coverage for 2025. Act before January 15 to enroll in health coverage that starts February 1. Image Enroll in health coverage now that meets your budget & needs Depending on your expected household income for the year, you or members of your household may qualify for lower costs or…
FIRE1 raised $120 million for its Norm system — a heart failure monitor implant that seeks to keep patients out of the hospital. The post Irish Startup Snags $120M for Heart Failure Implant appeared first on MedCity News.